ClearBridge Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.21B | Sell |
2,700,975
-159,201
| -6% | -$74.2M | 1.05% | 16 |
|
|
2025
Q4 | $1.3B | Buy |
2,860,176
+214,412
| +8% | +$92.4M | 1.04% | 12 |
|
|
2025
Q3 | $1.04B | Buy |
2,645,764
+1,117,900
| +73% | +$467M | 0.78% | 23 |
|
|
2025
Q2 | $680M | Sell |
1,527,864
-151,307
| -9% | -$69.7M | 0.55% | 44 |
|
|
2025
Q1 | $814M | Sell |
1,679,171
-171,687
| -9% | -$80M | 0.71% | 28 |
|
|
2024
Q4 | $745M | Sell |
1,850,858
-121,197
| -6% | -$56.2M | 0.6% | 40 |
|
|
2024
Q3 | $917M | Sell |
1,972,055
-118,649
| -6% | -$57M | 0.72% | 31 |
|
|
2024
Q2 | $980M | Sell |
2,090,704
-337,751
| -14% | -$147M | 0.8% | 23 |
|
|
2024
Q1 | $1.02B | Sell |
2,428,455
-164,120
| -6% | -$69.4M | 0.8% | 18 |
|
|
2023
Q4 | $1.05B | Sell |
2,592,575
-350,609
| -12% | -$130M | 0.91% | 14 |
|
|
2023
Q3 | $1.02B | Sell |
2,943,184
-208,238
| -7% | -$72.8M | 0.98% | 12 |
|
|
2023
Q2 | $1.11B | Sell |
3,151,422
-186,319
| -6% | -$62.8M | 1% | 14 |
|
|
2023
Q1 | $1.05B | Sell |
3,337,741
-148,379
| -4% | -$44.5M | 1% | 14 |
|
|
2022
Q4 | $1.01B | Sell |
3,486,120
-414,736
| -11% | -$126M | 0.99% | 14 |
|
|
2022
Q3 | $1.13B | Sell |
3,900,856
-342,408
| -8% | -$98.5M | 1.14% | 12 |
|
|
2022
Q2 | $1.2B | Sell |
4,243,264
-909,488
| -18% | -$243M | 1.11% | 12 |
|
|
2022
Q1 | $1.34B | Sell |
5,152,752
-43,978
| -0.8% | -$10.4M | 1.01% | 16 |
|
|
2021
Q4 | $1.14B | Buy |
5,196,730
+84,326
| +2% | +$16.4M | 0.78% | 23 |
|
|
2021
Q3 | $927M | Buy |
5,112,404
+129,810
| +3% | +$25.3M | 0.66% | 32 |
|
|
2021
Q2 | $1B | Sell |
4,982,594
-538,616
| -10% | -$113M | 0.7% | 28 |
|
|
2021
Q1 | $1.19B | Buy |
5,521,210
+1,244,784
| +29% | +$273M | 0.88% | 21 |
|
|
2020
Q4 | $1.01B | Sell |
4,276,426
-194,854
| -4% | -$44.7M | 0.78% | 25 |
|
|
2020
Q3 | $1.22B | Buy |
4,471,280
+304,248
| +7% | +$83.9M | 1.05% | 18 |
|
|
2020
Q2 | $1.21B | Buy |
4,167,032
+325,938
| +8% | +$88.4M | 1.09% | 17 |
|
|
2020
Q1 | $914M | Sell |
3,841,094
-283,619
| -7% | -$65.1M | 0.99% | 19 |
|
|
2019
Q4 | $905M | Sell |
4,124,713
-891,172
| -18% | -$180M | 0.75% | 30 |
|
|
2019
Q3 | $850M | Sell |
5,015,885
-161,981
| -3% | -$28.7M | 0.74% | 31 |
|
|
2019
Q2 | $950M | Sell |
5,177,866
-136,839
| -3% | -$23.9M | 0.82% | 30 |
|
|
2019
Q1 | $978M | Sell |
5,314,705
-168,447
| -3% | -$31.1M | 0.86% | 27 |
|
|
2018
Q4 | $909M | Sell |
5,483,152
-62,814
| -1% | -$10.9M | 0.92% | 21 |
|
|
2018
Q3 | $1.07B | Sell |
5,545,966
-454,501
| -8% | -$80.9M | 0.92% | 19 |
|
|
2018
Q2 | $1.02B | Sell |
6,000,467
-390,259
| -6% | -$60.5M | 0.83% | 23 |
|
|
2018
Q1 | $1.04B | Sell |
6,390,726
-294,943
| -4% | -$48.2M | 0.98% | 18 |
|
|
2017
Q4 | $1B | Sell |
6,685,669
-394,502
| -6% | -$58.4M | 0.93% | 19 |
|
|
2017
Q3 | $1.08B | Sell |
7,080,171
-838,582
| -11% | -$126M | 1.04% | 15 |
|
|
2017
Q2 | $1.02B | Sell |
7,918,753
-835,865
| -10% | -$101M | 1% | 14 |
|
|
2017
Q1 | $957M | Buy |
8,754,618
+105,260
| +1% | +$9.27M | 0.96% | 16 |
|
|
2016
Q4 | $637M | Buy |
8,649,358
+1,350,349
| +19% | +$110M | 0.7% | 29 |
|
|
2016
Q3 | $637M | Sell |
7,299,009
-275,774
| -4% | -$26.1M | 0.72% | 31 |
|
|
2016
Q2 | $652M | Sell |
7,574,783
-48,541
| -0.6% | -$4.19M | 0.77% | 25 |
|
|
2016
Q1 | $606M | Sell |
7,623,324
-88,934
| -1% | -$8.04M | 0.72% | 29 |
|
|
2015
Q4 | $970M | Sell |
7,712,258
-80,021
| -1% | -$9.66M | 1.12% | 13 |
|
|
2015
Q3 | $811M | Sell |
7,792,279
-69,102
| -0.9% | -$8.88M | 0.97% | 15 |
|
|
2015
Q2 | $971M | Sell |
7,861,381
-64,673
| -0.8% | -$8.15M | 1.03% | 13 |
|
|
2015
Q1 | $935M | Buy |
7,926,054
+402,429
| +5% | +$48.2M | 0.97% | 15 |
|
|
2014
Q4 | $894M | Sell |
7,523,625
-75,546
| -1% | -$8.51M | 0.94% | 14 |
|
|
2014
Q3 | $853M | Buy |
7,599,171
+49,753
| +0.7% | +$4.74M | 0.94% | 16 |
|
|
2014
Q2 | $715M | Buy |
7,549,418
+292,041
| +4% | +$20.5M | 0.8% | 23 |
|
|
2014
Q1 | $513M | Buy |
7,257,377
+355,907
| +5% | +$28.2M | 0.61% | 38 |
|
|
2013
Q4 | $513M | Buy |
6,901,470
+1,013,429
| +17% | +$70.6M | 0.64% | 38 |
|
|
2013
Q3 | $446M | Buy |
5,888,041
+285,231
| +5% | +$22.7M | 0.62% | 36 |
|
|
2013
Q2 | $449M | Buy |
+5,602,810
| New | +$413M | 0.68% | 33 |
|
Other funds holding VRTX
VCM
VPM
ClearBridge Investments's VRTX Position: Q1 2026 in Review
ClearBridge Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 5.6% in Q1 2026, selling an estimated $74.2M and leaving 2,700,975 shares worth $1.21B. The position accounts for 1.05% of the portfolio, ranked #16.
ClearBridge Investments first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.34B in Q1 2022. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- ClearBridge Investments held 2,700,975 shares of Vertex Pharmaceuticals worth $1.21B as of Q1 2026.
- ClearBridge Investments sold 159,201 Vertex Pharmaceuticals shares in Q1 2026, an estimated $74.2M.
- Vertex Pharmaceuticals made up 1.05% of ClearBridge Investments's portfolio in Q1 2026, its #16 holding.
- ClearBridge Investments first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- ClearBridge Investments's Vertex Pharmaceuticals position peaked at $1.34B in Q1 2022.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on ClearBridge Investments's 13F filing for Q1 2026, filed 13 May 2026.